Trial Site Detail
Drug: |
Nilotinib and Imatinib |
|||
|---|---|---|---|---|
Trial: |
Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Terminated |
|||
Washington University School of Medicine660 S. Euclid Ave |
Principal Investigator: |
Joel Picus, MD |
|---|---|
Contact: |
Anne Thompson ethompso@dom.wustl.edu |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Washington University School of Medicine Website: |
http://www.siteman.wustl.edu/FindProtocol.aspx?id=625&mid=70 |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.